Three different polymorphisms of the DPYD gene associated with severe toxicity following administration of 5-FU: a case report

Background Dihydropyrimidine dehydrogenase deficiency secondary to polymorphisms in the DPYD gene can lead to significant toxicity associated with the administration of fluoropyrimidine chemotherapy.